• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number UNKNOWN
Device Problem Entrapment of Device (1212)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/28/2019
Event Type  Injury  
Manufacturer Narrative
The onyx will not be returned for evaluation as it was consumed in the event; therefore, product analysis cannot be performed.The device was not returned; therefore, the reported event could not be confirmed.The event happened in post onyx embolization; therefore, the cause of the event cannot be conclusively determined from the provided information.Per the marathon ifu (instructions for use): precautions ¿ ¿if catheter entrapment is suspected (with any embolic agent), fast catheter retrieval technique may result in catheter shaft separation and potential vascular damage.Do not apply more than 20 cm of traction to catheter to minimize risk of catheter separation.¿ per the onyx les ifu: warnings: ¿do not allow more than 1 cm of the onyx les to reflux back over catheter tip.Angioarchitecture, vasospasm, excessive onyx les reflux, or prolonged injection time may result in difficult catheter removal and potential entrapment.Excessive force to remove an entrapped catheter may cause serious intracranial hemorrhage.The long-term effects of an entrapped catheter that is left in a patient are unknown, but potentially could include clot formation, infection, or catheter migration.¿ related mdrs for this event: 2029214-2019-01117, 2029214-2019-01118.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that after onyx embolization, the catheter was unable to be removed, and when it was further pulled, the catheter was broken where was about 30 cm from the tip part.The broken piece left in aorta from middle cerebral artery (mca).The patient underwent embolization treatment for an arteriovenous malformation.There were no reports of patient injury in association with this event.The device prepared according to the instructions per the ifu.It was further reported that the catheter which remained in the patient¿s body could be removed during the explanation of arteriovenous malformation (avm).Avm was explanted by craniotomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
katcha taylor
9775 toledo way
irvine, CA 92618
9496801345
MDR Report Key9305241
MDR Text Key170459823
Report Number2029214-2019-01118
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Lot NumberNOT REPORTED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/29/2019
Initial Date FDA Received11/11/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-